Ethyol Pretreatment Reduces Gastrointestinal Side Effects of Bone Marrow Transplant in Myeloma Patients
Pretreating multiple myeloma patients with Ethyol (amifostine) prior to…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read morePretreating multiple myeloma patients with Ethyol (amifostine) prior to…
The Multiple Myeloma Research Foundation and Karyopharm Therapeutics are hoping…
Animal studies have shown that a new treatment strategy…
Multiple myeloma patients who received several prior lines…
A Phase 1 clinical trial that uses the gene…
The U.S. Food and Drug Admnistration will give…